| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Director | Common Stock | 29.3K | $267K | $9.11 | May 23, 2024 | Direct |
| Avalo Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 78.1K | Oct 1, 2021 | Direct | ||
| Phathom Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 17.5K | May 23, 2024 | Direct | ||
| Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | Jun 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| PHAT | Phathom Pharmaceuticals, Inc. | May 23, 2024 | 2 | $0 | 4 | May 24, 2024 | Director |
| SAGE | Sage Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| PHAT | Phathom Pharmaceuticals, Inc. | May 25, 2023 | 2 | $0 | 4 | May 30, 2023 | Director |
| SAGE | Sage Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| PHAT | Phathom Pharmaceuticals, Inc. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| AVTX | Avalo Therapeutics, Inc. | Oct 1, 2021 | 1 | $0 | 4 | Oct 4, 2021 | Chief Executive Officer, Director |
| AVTX | Cerecor Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Chief Executive Officer, Director |
| SAGE | Sage Therapeutics, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
| PHAT | Phathom Pharmaceuticals, Inc. | May 21, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |
| PHAT | Phathom Pharmaceuticals, Inc. | Oct 29, 2019 | 1 | $186K | 4 | Feb 18, 2022 | Director |